How many walked through the door?: the effect of hurricane Katrina evacuees on Houston emergency departments
Abstract
BACKGROUND: Hurricane Katrina necessitated the evacuation of over 200,000 New Orleans residents into Houston in the days after landfall. The already stressed emergency departments (EDs) were faced with a potential influx of patients suffering injuries and conditions exacerbated by the hurricane and resulting devastation.
OBJECTIVE: To examine the effect of Katrina evacuees on Houston EDs after the hurricane.
DESIGN: Data from visits to 25 Houston EDs in 2005 (n = 875,750) were analyzed to evaluate the impact of visits by Katrina evacuees (n = 8427).
MEASURES: Descriptive counts of ED visits by individuals with a FEMA designated disaster area zip code due to Katrina.
RESULTS: In September, immediately after Katrina, Houston-area EDs reported the lowest monthly total visits in 2005 despite treating 4518 evacuees that month. On aggregate, the increase in visits by evacuees did not overwhelm area EDs, as they coincided with a decrease in ED utilization by nonevacuees and over 20,000 evacuees were seen at medical clinics in the large shelters. The highest number of evacuee visits to an individual ED was 86, on September 1. The peak day of visits, totaling 364, occurred on September 3. The ED that bore 15% of total visits saw no more than 19 evacuees daily. Evacuee and nonevacuee visits dropped dramatically when hurricane Rita threatened Houston.
CONCLUSIONS: Houston EDs experienced an increase in visits by Katrina evacuees in the hurricane's aftermath. However, the initial surge…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 875,750 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.